The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls - PubMed (original) (raw)

The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

A J Cross et al. Psychopharmacology (Berl). 1978.

Abstract

It has been suggested that deterioration of central noradrenergic pathways may be responsible for the production of certain schizophrenic symptoms, and that such a degeneration might be reflected in lowered dopamine-beta-hydroxylase (DBH) activity in the brains of schizophrenics. The present study revealed that in rats lowered DBH activity was a sensitive index of noradrenergic degeneration. In the postmortem brains of 12 controls and 12 schizophrenics, however, no significant difference in DBH activity between controls and schizophrenics was found. DBH activity was relatively unstable postmortem and adversely affected by neuroleptic drugs, and these factors may have contributed to the previous finding of lowered DBH activity in the brains of schizophrenics. The activity of catechol-O-methyl transferase, which has also been previously reported as low in the brains of schizophrenics, was found to be no different in the controls of the present study.

PubMed Disclaimer

Similar articles

• Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients.
  Wise CD, Stein L. Wise CD, et al. Science. 1973 Jul 27;181(4097):344-7. doi: 10.1126/science.181.4097.344. Science. 1973. PMID: 4719906
• Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.
  Wyatt RJ, Schwartz MA, Erdelyi E, Barchas JD. Wyatt RJ, et al. Science. 1975 Jan 31;187(4174):368-70. doi: 10.1126/science.1111112. Science. 1975. PMID: 1111112
• Proceedings: Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.
  Wise CD, Stein L. Wise CD, et al. Psychopharmacol Bull. 1974 Jul;10(3):48-9. Psychopharmacol Bull. 1974. PMID: 4419423 No abstract available.
• Difficulties in comparing catecholamine-related enzymes from the brains of schizophrenics and controls.
  Wyatt RJ, Erdelyi E, Schwartz M, Herman M, Barchas JD. Wyatt RJ, et al. Biol Psychiatry. 1978 Jun;13(3):317-34. Biol Psychiatry. 1978. PMID: 27253
• CSF dopamine beta-hydroxylase in schizophrenia.
  Sternberg DE, van Kammen DP, Lerner P, Ballenger JC, Marder SR, Post RM, Bunney WE Jr. Sternberg DE, et al. Arch Gen Psychiatry. 1983 Jul;40(7):743-7. doi: 10.1001/archpsyc.1983.01790060041005. Arch Gen Psychiatry. 1983. PMID: 6134515

Cited by

• Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain.
  Schendzielorz N, Oinas JP, Myöhänen TT, Reenilä I, Raasmaja A, Männistö PT. Schendzielorz N, et al. PLoS One. 2013 Apr 16;8(4):e61392. doi: 10.1371/journal.pone.0061392. Print 2013. PLoS One. 2013. PMID: 23613844 Free PMC article.
• 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
  Cross AJ, Crow TJ, Owen F. Cross AJ, et al. Psychopharmacology (Berl). 1981;74(2):122-4. doi: 10.1007/BF00432676. Psychopharmacology (Berl). 1981. PMID: 6791218
• Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.
  Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE. Cross AJ, et al. Br Med J (Clin Res Ed). 1981 Jan 10;282(6258):93-4. doi: 10.1136/bmj.282.6258.93. Br Med J (Clin Res Ed). 1981. PMID: 6779929 Free PMC article.
• The biology of schizophrenia.
  Crow TJ. Crow TJ. Experientia. 1982 Nov 15;38(11):1275-82. doi: 10.1007/BF01954914. Experientia. 1982. PMID: 6129159 Review. No abstract available.
• Molecular pathology of schizophrenia: more than one disease process?
  Crow TJ. Crow TJ. Br Med J. 1980 Jan 12;280(6207):66-8. doi: 10.1136/bmj.280.6207.66. Br Med J. 1980. PMID: 6101544 Free PMC article. Review. No abstract available.

References

1. 1. Arch Gen Psychiatry. 1977 Jan;34(1):89-92 - PubMed
2. 1. Dis Nerv Syst. 1965 Feb;26:99-105 - PubMed
3. 1. J Neurochem. 1976 Oct;27(4):883-8 - PubMed
4. 1. Life Sci. 1965 Dec;4(24):2353-9 - PubMed
5. 1. Arch Gen Psychiatry. 1974 Nov;31(5):649-54 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Miscellaneous

  • NCI CPTAC Assay Portal